HPTN 052 is a clinical trial on HIV infection, which is declared as the most important scientific breakthrough of the year 2011, by the prestigious 'Science' journal. This clinical trial demonstrated that people infected with HIV are 96 per cent less likely to transmit the virus to their partners if they take antiretroviral drugs (ARVs).
